Srt Fabry Galafold denied due to quantity / dose limits by Aetna?
Quantity-limit denials usually flip when the appeal documents the clinically appropriate dose for the patient's weight, kidney function, or escalation schedule, citing the FDA label or specialty-society guideline.
US health-plan appeal rights
Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules
Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.
What Aetna typically requires
Aetna's specific coverage criteria for srt fabry galafold are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.
The Aetna angle on Srt Fabry Galafold
## Why Aetna Applies Quantity Limits to Galafold
Aetna's quantity-limit restrictions on Galafold are set based on the dosing regimen described in the FDA-approved prescribing label. When a prescription is written in a quantity or supply duration that does not align with the expected dispensing pattern for the approved regimen, the claim may be pended or denied at the pharmacy. This can also occur when a mail-order prescription is submitted for a quantity that differs from what the plan's specialty pharmacy benefit allows per fill.
Quantity-limit denials for Galafold are almost always administrative and correctable. The drug has a defined dosing schedule in its labeling, and the appeal simply needs to establish that the prescribed quantity is consistent with that schedule and the patient's clinically appropriate supply need.
## Your Federal Appeal Rights
ACA §2719 independent external review applies to quantity-limit denials in non-grandfathered plans. ERISA §503 full-and-fair review applies to employer-sponsored plans. The external review window is approximately four months from the denial notice. If the patient faces a gap in therapy due to the quantity limit, request expedited review to compress the timeline.
## How to Appeal a Quantity-Limit Denial
Step 1 — Verify the prescription: Confirm with the prescriber that the written quantity aligns with the dosing frequency in the FDA-approved prescribing label. If there is a discrepancy, a corrected prescription may resolve the denial without a formal appeal.
Step 2 — Request a quantity-limit exception: If the standard limit does not accommodate the patient's clinical need (for example, a short-cycle fill was submitted but the patient requires a full 90-day supply for continuity reasons), request a formal exception.
Step 3 — Document clinical necessity for the requested quantity: The prescriber should explain why the requested supply quantity is medically appropriate and consistent with the approved dosing schedule.
## Documentation to Gather
- Copy of the prescription as written, with prescriber contact details
- Aetna's published quantity-limit criteria for Galafold (request from the pharmacy or provider portal)
- The FDA-approved prescribing label showing the approved dosing schedule
- A brief prescriber letter confirming the prescribed quantity matches the standard treatment course and explaining any clinical rationale for a supply variation
- Diagnosis and chart documentation confirming the Fabry disease diagnosis and current treatment status
Present the quantity calculation clearly in the appeal letter: show how the prescribed amount maps to the approved dosing interval over the requested supply period so the reviewer can verify the request without ambiguity.
Next steps
- Find the date on the denial letter — your appeal window starts there.
- Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
- Request the insurer's claim file in writing — they must provide it.
- Submit your appeal in writing with new clinical evidence and a physician statement.
Get the letter drafted
DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.
Start my appeal — $30 with code SEO25 →